Opioids Prescribing in Dentistry – Opioid Continuing Education for Dentists

AGD PACE (National Approval) Approved Dental Continuing Education Provider
Fulfills Mandatory Opioids Prescribing / Controlled Substances CE Requirements


Opioids Prescribing in DentistryOpioids Prescribing in Dentistry- 3 Hours 
Course Curriculum: Click Here
Fulfills Mandatory Opioids Prescribing in Dentistry / Controlled Substances Continuing Education Requirements 
$30

Opioids Prescribing in Dentistry: Prescription opioids are often used to control acute pain after dental procedures such as tooth extractions, placement of dental implants, and endodontic and periodontal surgeries. Opioids are also prescribed in emergency departments (EDs) to manage dental pain until treatment can be started. Regular use of opioids—even as prescribed by a health care provider—can lead to dependence and, when misused, can lead to addiction, overdose, and death. Furthermore, large numbers of opioid pills left unused after a dental procedure are available for theft, diversion, or later misuse by others.

Continuing education for healthcare providers is one way we might be able to improve opioid prescription practices, and in turn, reduce misuse and overdose deaths. By making sure that everyone who prescribes an opioid – doctors, dentists, nurse practitioners, physician assistants, and so on – has the training to decide when opioid medications should and shouldn’t be used, prescribers might be able to limit these drugs to only those patients who will therapeutically benefit from them, and avoid prescribing them when other pain management options might be more effective. It’s not just about finding the right drug and dose – it’s also about considering alternatives, dispensing just the right number of pills at a time, avoiding side effects, recognizing misuse, and so on. 

This three hours “Opioids Prescribing in Dentistry” outlines opioid prescribing principles for general dentists and dental specialists with emphasis on the safe and competent use of opioids for managing acute moderate to severe dental pain. The course provides most current information on minimizing opioid abuse through patient education, careful patient assessment and screen patients for substance use disorders when indicated, and using tools such as prescription monitoring programs.

Upon completion of this course, you will be able to learn:

  • The epidemiology and the genesis of the opioid crisis
  • Trends in opioid prescribing by specialties
  • The types of opioids and their pharmacokinetics
  • The effect of opioid pain medications on body & brain
  • Commonly prescribed opioid and NSAIDs in dentistry and their side effects
  • Opioid tolerance and withdrawals symptoms
  • Pharmacologic agents used to treat opioid disorder (opioid antagonists)
  • The risks of abuse and addiction associated with opioid medication
  • The sources of misused prescription opioids
  • Guidelines on the use of opioids in dental practice
  • Screening for substance abuse in dental practice
  • Prescription Drug Monitoring Programs (PDMPs) and Impact of a mandatory PDMP on prescription opioid analgesics by dentists
  • The ADA statement on the use of opioids in the treatment of dental pain

Opioids Prescribing in Dentistry Continuing Education Requirement by States: Most States have passed or are in process of passing legislation and adopting containing education requirements for dental professionals in regards to opioids prescribing / controlled substances continuing education requirements for dentists. Please visit your state licensing board’s website for the most current continuing education requirements.

Academy of General DentistryAGD PACE Approval (Click Here): Biologix Solutions LLC is designated as an Approved PACE Program Provider by the Academy of General Dentistry. The formal continuing dental education programs of this program provider are accepted by AGD for Fellowship, Mastership, and membership maintenance credit. Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement. The current term of approval extends from 4/20/2013 to 4/30/2021. Provider ID: 352738.

LoadingUpdating...